
11 September 2026: Integris Medtech has appointed Dev Tripathy as its new Group Chief Financial Officer (CFO). In this role, he will manage the company’s global financial operations, capital allocation, governance, and risk management frameworks across its cardiovascular and laboratory solutions businesses.
Taking on this mandate, Dev will focus on building scalable financial processes, strengthening internal controls, and supporting the company’s international operations and manufacturing facilities across India, Germany, and the Netherlands.
He has over two decades of finance leadership experience, including more than 18 years at Philips. Most recently, he served as CFO for the Philips India Subcontinent and Growth Region Image Guided Therapy. His earlier leadership positions at Philips included Director of Finance for Health Systems (India Subcontinent), Director of Finance for Personal Health, Director of Finance for Corporate Functions, Head of FP&A for the India Subcontinent, and Regional Transition Manager for Asia-Pacific. Earlier in his career, he served as Controller at AB Mauri India. He is a Chartered Accountant from the Institute of Chartered Accountants of India (ICAI) and completed executive education in Strategy and Business Decision Making from IIM Ahmedabad.
Commenting on his appointment, Dev stated: “After over 18 years at Philips, I felt increasingly drawn to a different challenge: building rather than managing. What attracted me to Integris is the opportunity to shape finance from the ground up and make it a true partner in the company’s growth journey.”
Curated by SSF Global
Tracking the shifts shaping GCCs, enterprise ecosystems, and the future of global business.

Ask an Expert
